Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-02-16

Clinical Trial Update: PRospective Evaluation Comparing Initiation of Warfarin StrategiEs (PRECISE): Pharmacogenetic-guided Versus Usual Care [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing pharmacogenetic-guided warfarin initiation versus usual care has been withdrawn. The sponsor is University of Florida and the conditio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Warfarin (warfarin)

Snippet

Sponsor: University of Florida | Conditions: Blood Coagulation Disorders | Phase 4 | Status: WITHDRAWN